Post by
Mil_Man54 on Dec 21, 2020 10:04am
dayanpantig01.....New Pumper Account
We have a brand new one folks....pumping HUGE, TRIP, and GRAT.....spammed all 3 boards with about 2 pages a piece of PR BS and lying pumps.....same scripts as all the other pumpers....ignore and report them.
Comment by
GrahamB on Dec 21, 2020 7:49pm
Maybe they will post in the next week or so that a second patient has enrolled in the trials. 'Or that a second patient is scheduled to enroll. Maybe a video to promote it?
Comment by
Mil_Man54 on Dec 21, 2020 9:12pm
....I'm expecting they'll be ringing the bell again for news like that...LOL
Comment by
Mil_Man54 on Dec 21, 2020 9:11pm
Because you're a multi account pumper who posts lies and misleading information and you need o be called out....
Comment by
pdelics21 on Dec 22, 2020 7:44am
The primary objective of the trial is to analyse whether FSD201 plus SOC can significantly improve patients’ clinical status such as shorter time to symptom relief. Progress is on the way with this biotech company.
Comment by
pdelics21 on Dec 22, 2020 7:38am
Patient are being qualified first, so time is essential before we can see the results.
Comment by
Renofund on Dec 22, 2020 9:09am
hear that folks? It is a "SURE-FIRE win in the future" LOL.
Comment by
pdelics21 on Dec 22, 2020 7:45am
I’m excited for FSD Pharma to go big. Really! FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system.
Comment by
pdelics21 on Dec 22, 2020 7:46am
They are advancing in the pharmaceutical industry using biotechnology treating immunodeficiency diseases such as sickle cell and fibromyalgia.
Comment by
pdelics21 on Dec 22, 2020 7:47am
I myself is suffering from alopecia and I can see the light for thi company going big 2021.
Comment by
Stockhouse2021 on Dec 22, 2020 7:49am
I agree. FSD201 is something nonsteroidal and is also focused on getting forward sooner or later on its fight with sickle cell disease.